Pefloxacin in adriamycin induced nephrotic syndrome in the rat

Nephrology Dialysis Transplantation

Volumn 12, Issue 2, 1997, Pages 286-288

  Korzets, Z ^b   Pomeranz, A ^b   Golan, E ^b   Bernheim, J ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Adriamycin; Nephrotic syndrome; Pefloxacin; Rat

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DOXORUBICIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; MALE; NEPHROTIC SYNDROME; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; MALE; NEPHROTIC SYNDROME; PEFLOXACIN; PROTEINURIA; RATS; RATS, WISTAR;

EID: 0031054591     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.2.286     Document Type: Article

References (16)

1. Pruna A, Akposso K, Bedrossian J et al. Pefloxacin as first line treatment in nephrotic syndrome. Lancet 1992; 340: 728-729
2. Berthoux FC, Alamartine E, Hacini J et al. Short term effect of pefloxacin on heavy proteinuria in glomerular diseases: a preliminary experience. XIIth International Congress of Nephrology, Jerusalem, June 1993, p 28 (abst)
3. Geffriaud-Ricouard C, Jungers P, Chauveau D et al. Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid resistant nephrotic syndrome. Lancet 1993; 341: 1475
4. Aigrain EJ, Brun PH, Bennasr S et al. Side effects of pefloxacin in idiopathic nephrotic syndrome. Lancet 1993; 342: 438-439
5. Ginsburg C, Toledano D, Deray G et al. Pefloxacin as first line treatment in nephrotic syndrome. Nephrol Dial Transplant 1994; 9: 335
6. Okasora T, Takikawa T, Utsunomiya Y et al. Suppressive effect of superoxide dismutase on adriamycin nephropathy. Nephron 1992; 60: 199-203
7. Podjarny E, Rathaus M, Bernheim J et al. Captopril but not diltiazem favourably affects the course of early chronic disease in rats. Nephron 1990; 55: 196-202
8. st Congress of ERA-EDTA, Vienna, July 1994, p 46 (abst)
9. Koyama A, Fujisaki M, Kobayashi M et al. A glomerular permeability factor produced by human T-cell hybridomas. Kidney Int 1991; 40: 453-460
10. Hinoshita F, Noma T, Tomura S et al. Decreased production and responsiveness of interleukin-2 in lymphocytes of patients with nephrotic syndrome. Nephron 1990; 54: 122-126
11. Bricio T, Molina A, Egido J et al. IL 1-like production in adriamycin induced nephrotic syndrome in the rat. Clin Exp Immunol 1992; 87: 117-121
12. Roche Y, Desnottes JF, Gougerot-Pocidalo MA et al. Quinolones et fonctions immunes. In: Pocidalo, Vachon, Regnier, eds. Les Nouvelles Quinolones. Arnette Ed, 1985; 103-108
13. Forsgren A, Bredberg A, Riesbeck K. New quinolones: in vitro effects as a potential source of clinical toxicity. Rev Infect Dis 1989; 11 [Suppl 5]: S1382-S1389
14. Zima T, Tesaf V, Rychlik I et al. Effect of pefloxacin on experimental adriamycin induced nephrotic syndrome. Nephrol Dial Transplant 1995; 10: 1472
15. Sellers AL, Goodman HC, Marmorston J et al. Sex difference in proteinuria in the rat. Am J Physiol 1950; 163: 662-667
16. Gafter U, Ben-Bassat M, Levi J. Castration inhibits glomerular hypertrophy and proteinuria in uninephrectomized male rats. Eur J Clin Invest 1990; 20: 360-365